VVOS · Vivos Therapeutics, Inc. · Short Volume
$0.18
+0.01 (+6.70%)
At close · Sep 10
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had approximately $1.8 million in cash and cash equivalents, which will not be sufficient to fund operations and strategic objectives over the next twelve months from the date of the issuance of these financial statements. Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.42M
Shares
20.12M
Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.
Short Volume
| Date | Short Volume | Short Exempt | Total Volume | Short % |
|---|---|---|---|---|
| 2026-09-10 | 392,010 | 1,776 | 1,133,775 | 34.6% |
| 2026-09-09 | 2,425,157 | 86,274 | 5,635,479 | 43.0% |
| 2026-09-08 | 650,410 | 657 | 1,481,566 | 43.9% |
| 2026-09-04 | 1,476,243 | 400 | 2,290,837 | 64.4% |
| 2026-09-03 | 1,442,146 | 38,652 | 2,350,660 | 61.4% |
| 2026-09-02 | 2,249,207 | 394,690 | 3,921,873 | 57.4% |
| 2026-09-01 | 3,866,989 | 978,920 | 7,364,616 | 52.5% |
| 2026-08-31 | 98,540,240 | 27,942,693 | 167,076,407 | 59.0% |
| 2026-08-28 | 1,092,972 | 40,949 | 1,917,711 | 57.0% |
| 2026-08-27 | 320,426 | 0 | 629,021 | 50.9% |
| 2026-08-26 | 661,869 | 0 | 1,172,533 | 56.4% |
| 2026-08-25 | 245,957 | 0 | 436,514 | 56.3% |
| 2026-08-24 | 49,548 | 0 | 161,918 | 30.6% |
| 2026-08-21 | 46,671 | 0 | 59,901 | 77.9% |
| 2026-08-20 | 274,192 | 21,772 | 361,706 | 75.8% |
| 2026-08-19 | 126,688 | 7,122 | 243,584 | 52.0% |
| 2026-08-18 | 56,959 | 11,167 | 120,287 | 47.4% |
| 2026-08-17 | 141,463 | 9,502 | 371,319 | 38.1% |
| 2026-08-14 | 695,576 | 0 | 1,018,588 | 68.3% |
| 2026-08-13 | 281,197 | 48,154 | 432,880 | 65.0% |
| 2026-08-12 | 363,203 | 92,548 | 661,007 | 54.9% |
| 2026-08-11 | 1,806,131 | 20,179 | 3,411,733 | 52.9% |
| 2026-08-10 | 79,572 | 0 | 328,210 | 24.2% |
| 2026-08-07 | 230,033 | 8,780 | 730,987 | 31.5% |
| 2026-08-06 | 249,618 | 39,575 | 468,680 | 53.3% |
| 2026-08-05 | 1,450,884 | 266,433 | 2,523,335 | 57.5% |
| 2026-08-04 | 782,811 | 700 | 1,394,252 | 56.1% |
| 2026-08-03 | 13,003 | 0 | 49,405 | 26.3% |
| 2026-07-31 | 18,050 | 0 | 134,908 | 13.4% |
| 2026-07-30 | 14,111 | 0 | 28,155 | 50.1% |
| 2026-07-29 | 66,835 | 0 | 138,097 | 48.4% |
| 2026-07-28 | 72,536 | 0 | 155,554 | 46.6% |
| 2026-07-27 | 18,739 | 0 | 51,037 | 36.7% |
| 2026-07-24 | 48,379 | 0 | 112,366 | 43.1% |
| 2026-07-23 | 81,779 | 0 | 115,751 | 70.7% |
| 2026-07-22 | 34,531 | 0 | 95,433 | 36.2% |
| 2026-07-21 | 31,726 | 0 | 68,553 | 46.3% |
| 2026-07-20 | 18,141 | 0 | 35,948 | 50.5% |
| 2026-07-17 | 22,076 | 0 | 84,936 | 26.0% |
| 2026-07-16 | 36,769 | 0 | 105,511 | 34.8% |
| 2026-07-15 | 4,143 | 0 | 23,357 | 17.7% |
| 2026-07-14 | 98,357 | 4,236 | 150,012 | 65.6% |
| 2026-07-13 | 33,677 | 0 | 85,459 | 39.4% |
| 2026-07-10 | 32,138 | 0 | 92,805 | 34.6% |
| 2026-07-09 | 35,135 | 0 | 50,793 | 69.2% |
| 2026-07-08 | 39,318 | 614 | 73,753 | 53.3% |
| 2026-07-07 | 45,637 | 1,545 | 67,329 | 67.8% |
| 2026-07-06 | 19,600 | 3,838 | 48,704 | 40.2% |
| 2026-07-02 | 92,880 | 5,981 | 212,976 | 43.6% |
| 2026-07-01 | 112,230 | 4,495 | 226,130 | 49.6% |
Showing 1–50 of 63 days
Key facts
CIK
1716166
CUSIP
92859E207
13F (30d)
11 filings
11 filers
Visit website
Investor relations